How better financing could help create new cancer drugs

The pharmaceuticals industry presents a quandary for potential investors: Major investments in drug development pay off handsomely in a relatively small number of cases, but many other projects deliver no returns at all. ...

Money managers, analysts comment on Facebook IPO

Facebook is finally going public. For investors lucky enough to get in on the IPO, the question is simple: Is this going to be the mother lode that puts their kids through college? Or an over-hyped dud?

page 2 from 3